title: Proposal on Raloxifene use after prophylactic salpingo-oophorectomy in BRCA1-2: hypothesis and rationale.
authors.affiliation: Department of Woman and Child Health, Obstetric and Gynaecologic Clinic, University of Padua, Padua, Italy.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Gizzo
authors.forename: Marco
authors.initials: M
authors.lastname: Noventa
authors.forename: Carlo
authors.initials: C
authors.lastname: Saccardi
authors.forename: Pietro
authors.initials: P
authors.lastname: Litta
authors.forename: Donato
authors.initials: D
authors.lastname: D'Antona
authors.forename: Giovanni B
authors.initials: GB
authors.lastname: Nardelli
mesh_terms: D019313:BRCA1 Protein / Q000235:genetics*; D024682:BRCA2 Protein / Q000235:genetics*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism; D002319:Cardiovascular System / Q000187:drug effects; D003131:Combined Modality Therapy; D005185:Fallopian Tube Neoplasms / Q000235:genetics / Q000517:prevention & control*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics / Q000517:prevention & control*; D010052:Ovariectomy; D065286:Prophylactic Surgical Procedures; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*; D058994:Salpingectomy
chemical_list: D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D024682:BRCA2 Protein; C551750:BRCA2 protein, human; D050071:Bone Density Conservation Agents; D020849:Raloxifene Hydrochloride